Jayme, Gloria B.
HRN: 01-87-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2023
CEFTAZIDIME 1GM (VIAL)
10/27/2023
11/03/2023
IV
1g
Q8H
CAP MR Presumptive PTB; Sepsis
Checking Final Appropriateness
Indication: Empirical Escalation Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes